Pain Therapeutics, Inc. (NASDAQ:PTIE)

CAPS Rating: 3 out of 5

A biopharmaceutical company that develops novel drugs for pain management and oncology.

Recs

0
Player Avatar razormd (38.11) Submitted: 8/22/2007 11:32:20 AM : Outperform Start Price: $7.31 PTIE Score: -43.58

Nothing much to add to what has already been noted by other CAPS players.

Report this Post Reply

Featured Broker Partners


Advertisement